Raadysan Biotech, Inc.

We are developing revolutionary Small Molecule Therapies for Triple Negative Breast Cancer. We are developing multiplex PCR kit for the detection of Triple Negative Breast Cancer. Raadysan Biotech, Inc., is a biotechnology company that is involved in the Research & Development of its highly differentiated therapies for Triple Negative Breast Cancer. Taylor has expertise in all aspects of medicinal chemistry including structure based drug design, HTS screens, and fast follower approaches, GMP manufacture, quality, formulation, analytical chemistry and regulatory development. Pohl is a member of the American Association of Pharmaceutical Scientists (AAPS), European Association for the Study of Diabetes (EASD), Controlled Release Society (CRS), American Diabetes Association (ADA) and American Chemical Society (ACS). Phillips is a board-certified Hematologist and Medical Oncologist. Landekic served as the President & Chief Executive Officer, Director, at Locus Discovery Inc., Blue Bell, Pennsylvania, and earned for the company the accolade “One of the 10 hottest biotechnology start-ups” by Drug Discovery Today magazine, Feb. Mieyal has over 15 years of experience in healthcare investments.